A global pharmaceutical company specializing in generic and specialty medicines, Teva is one of the largest producers of generic drugs worldwide. Investors monitor its performance due to its significant role in reducing healthcare costs and its ongoing legal settlements related to opioid litigation.
2 members of Congress have disclosed 5 trades in Teva Pharmaceutical Industries Limited (TEVA), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2005-08-07 | Randy Neugebauer | sell | $1K – $15K |
| 2005-08-07 | Randy Neugebauer | sell | $1K – $15K |
| 2002-02-10 | MICHAEL T. MCCAUL | buy | $15K – $50K |
| 2002-01-10 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2001-09-09 | MICHAEL T. MCCAUL | buy | $1K – $15K |